Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tansy Edwards

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Emerging Infectious Diseases|December 22, 2020
Estimating the Force of Infection for Dengue Virus Using Repeated Serosurveys, Ouagadougou, Burkina FasoJacqueline K Lim, Mabel Carabali, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Plos Neglected Tropical Diseases|December 7, 2019
Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina FasoJacqueline K Lim, Yaro Seydou, Mabel Carabali, et al.
The New England Journal of Medicine|August 6, 2025
Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic PlagueRindra Vatosoa Randremanana, Mihaja Raberahona, Josephine Bourner, et al.
Plos Neglected Tropical Diseases|January 18, 2019
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in EthiopiaErmias Diro, Severine Blesson, Tansy Edwards, et al.
Tropical Medicine and Health|October 11, 2022
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysisGreco Mark B Malijan, Tansy Edwards, Kristal An Agrupis, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Transfusion|March 25, 2018
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra LeoneRichard S Tedder, Dhan Samuel, Steve Dicks, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Emerging Infectious Diseases|December 22, 2020
Estimating the Force of Infection for Dengue Virus Using Repeated Serosurveys, Ouagadougou, Burkina FasoJacqueline K Lim, Mabel Carabali, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Plos Neglected Tropical Diseases|December 7, 2019
Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina FasoJacqueline K Lim, Yaro Seydou, Mabel Carabali, et al.
The New England Journal of Medicine|August 6, 2025
Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic PlagueRindra Vatosoa Randremanana, Mihaja Raberahona, Josephine Bourner, et al.
Plos Neglected Tropical Diseases|January 18, 2019
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in EthiopiaErmias Diro, Severine Blesson, Tansy Edwards, et al.
Tropical Medicine and Health|October 11, 2022
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysisGreco Mark B Malijan, Tansy Edwards, Kristal An Agrupis, et al.
Plos Neglected Tropical Diseases|January 24, 2014
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, et al.
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
Plos Neglected Tropical Diseases|September 15, 2016
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialMonique Wasunna, Simon Njenga, Manica Balasegaram, et al.
Transfusion|March 25, 2018
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra LeoneRichard S Tedder, Dhan Samuel, Steve Dicks, et al.
Pageof 9